We are live on ! Find out more
INBS icon

Intelligent Bio Solutions

8 hedge funds and large institutions have $151K invested in Intelligent Bio Solutions in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

522% more capital invested

Capital invested by funds: $24.3K → $151K (+$127K)

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

167% more funds holding

Funds holding: 38 (+5)

0.03% more ownership

Funds ownership: 0.01%0.04% (+0.03%)

Holders
8
Holders Change
+5
Holders Change %
+166.67%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

INBS Hedge Fund Activity: Q4 2023 in Review

8 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q4 2023, worth a combined $151K — up 522% from $24.3K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new INBS positions and 1 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $51.2K. The largest seller was ORG Partners, exiting entirely with an estimated $5.15K sold.

  • 8 institutional investors held Intelligent Bio Solutions (INBS) as of Q4 2023, up from 3 in Q3 2023.
  • Funds reported $151K of Intelligent Bio Solutions stock for Q4 2023, up 522% quarter-over-quarter.
  • 6 funds opened new Intelligent Bio Solutions positions in Q4 2023 and 1 closed out, a net change of +5 holders.
  • The largest Intelligent Bio Solutions buyer in Q4 2023 was Citadel Advisors, an estimated $51.2K added.
  • The largest Intelligent Bio Solutions seller in Q4 2023 was ORG Partners, an estimated $5.15K sold.

Based on aggregated 13F filings for Q4 2023.